bisantrene has been researched along with Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ludwig, C | 1 |
| Kuhn, JG; Myers, JW; Osborne, CK; Pocelinko, R; Sandbach, JF; Von Hoff, DD | 1 |
| Clark, GM; Cowan, JD; Von Hoff, DD | 1 |
| Kuhn, JG; Ludden, TM; Myers, JW; Von Hoff, DD | 1 |
| Alberts, DS; Mackel, C; Pocelinko, R; Salmon, SE | 1 |
| Bedikian, AY; Blumenschein, GR; Bodey, GP; Pocelinko, R; Yap, BS; Yap, HY | 1 |
| Alberts, DS; Dorr, RT; Einspahr, J; Milton, S; Remers, WA; Tunget, CL; Wunz, TP | 1 |
| Avery, L; Choi, K; Crom, DB; Douglass, EC; Etcubanas, E; Pratt, CB; Sinkule, JA | 1 |
1 trial(s) available for bisantrene and Neoplasms
| Article | Year |
|---|---|
Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.
Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antineoplastic Agents; Cell Survival; Clinical Trials as Topic; Colony-Forming Units Assay; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Melanoma; Middle Aged; Multiple Myeloma; Neoplasms; Urinary Bladder Neoplasms | 1982 |
7 other study(ies) available for bisantrene and Neoplasms
| Article | Year |
|---|---|
Drug resistance of hypoxic tumour cells in vitro.
Topics: Animals; Anthracenes; Cell Line; DNA, Single-Stranded; Drug Evaluation, Preclinical; Drug Resistance; Humans; Hypoxia; Leukemia L1210; Mice; Mitomycin; Mitomycins; Neoplasms; Neoplastic Stem Cells; Stem Cells | 1984 |
Anaphylactoid reactions associated with bisantrene infusions.
Topics: Anaphylaxis; Anthracenes; Drug Evaluation; Humans; Infusions, Parenteral; Neoplasms | 1983 |
Comparative cytotoxicity of adriamycin, mitoxantrone and bisantrene as measured by a human tumor cloning system.
Topics: Anthracenes; Anthraquinones; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Separation; Cell Survival; Clone Cells; Colony-Forming Units Assay; Doxorubicin; Drug Evaluation; Humans; Lymph Nodes; Mitoxantrone; Neoplasms; Tumor Stem Cell Assay | 1983 |
Characterization of the pharmacokinetics of bisantrene (NSC-337766).
Topics: Aged; Anthracenes; Antibiotics, Antineoplastic; Chromatography, High Pressure Liquid; Humans; Kinetics; Male; Middle Aged; Neoplasms | 1983 |
Phase I clinical evaluation of 9,10-anthracenedicarboxyaldehyde[bis(4,5-dihydro-1H-imidazol-2-yl)hydrazone]dihydrochloride (bisantrene).
Topics: Adult; Aged; Anthracenes; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms | 1982 |
New antitumor agents containing the anthracene nucleus.
Topics: Animals; Anthracenes; Cell Line; Chemical Phenomena; Chemistry; DNA; Humans; Leukemia L1210; Leukemia P388; Mice; Mitoxantrone; Neoplasms; Protein Biosynthesis; RNA; Structure-Activity Relationship | 1987 |
Phase I clinical and pharmacokinetic study of bisantrene in refractory pediatric solid tumors.
Topics: Adolescent; Adult; Anthracenes; Child; Child, Preschool; Drug Evaluation; Female; Humans; Male; Metabolic Clearance Rate; Neoplasms | 1986 |